Recent Finacing
Recent Raise
Eureka Therapeutics is a clinical-stage Bay Area biotech developing ARTEMIS AbTCR and E-ALPHA antibody discovery platforms to engineer TCR-mimic antibodies and T cell therapies targeting intracellular peptide/MHC cancer antigens.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
